title: Cancer size, histotype, and cellular grade may limit the success of fine-needle aspiration cytology for screen-detected breast carcinoma.
abstract: BACKGROUND
  Fine-needle aspiration cytology (FNAC) was adopted as the first-line method to assess breast lesions in the Verona Breast Cancer Screening Program. The radiological and pathological factors relating to the success of FNAC in breast cancer series were evaluated.
  
  
  METHODS
  Between July 1999 and June 2004, 418 breast cancers were submitted to FNAC in the Verona Breast Cancer Screening Program. The results of FNAC diagnoses were compared with final histology. The FNAC sensitivity rate, underestimation of malignancy rate, and inadequacy rate were correlated with histotype, size, grading, and radiologic imaging.
  
  
  RESULTS
  Of the 418 cancers, 95 were in situ, and 323 were invasive. The sensitivity rate was higher in invasive cancers (P < .001), and the underestimation of malignancy rate was greater in in situ cancers (P = .002). Lobular type cancers had a lower sensitivity rate in invasive and in situ cancers. The sensitivity rate was 100% in medullary, mucinous, and papillary cancers, and no case had inadequate sampling. The underestimation of malignancy rate was higher in tubular carcinoma (18.2%); lobular carcinoma showed a higher inadequacy rate (10.4%). The sensitivity rate was lower and the underestimation of malignancy rate was higher in low-grade carcinomas and in lesions <1 cm (P < .001). The performance of FNAC was not significantly influenced by mammographic imaging of lesions.
  
  
  CONCLUSIONS
  Low-grade cancer histotype, cancer size <1 cm, and lobular and tubular histotypes limit the possibility of obtaining positive results by FNAC. Operator experience and multidisciplinary consultation may help in overcoming these limitations. Pathologists must be aware of the limits of FNAC; results must be critically evaluated in light of the triple assessment.
authors.affiliation: Institute of Pathology, Department of Pathology, University of Verona, Verona, Italy. erminia.manfrin@univr.it
authors.forename: Erminia
authors.initials: E
authors.lastname: Manfrin
authors.forename: Francesca
authors.initials: F
authors.lastname: Falsirollo
authors.forename: Andrea
authors.initials: A
authors.lastname: Remo
authors.forename: Daniela
authors.initials: D
authors.lastname: Reghellin
authors.forename: Renata
authors.initials: R
authors.lastname: Mariotto
authors.forename: Daniela
authors.initials: D
authors.lastname: Dalfior
authors.forename: Elena
authors.initials: E
authors.lastname: Piazzola
authors.forename: Franco
authors.initials: F
authors.lastname: Bonetti
mesh_terms: D044963:Biopsy, Fine-Needle; D001943:Breast Neoplasms / Q000175:diagnosis / Q000473:pathology*; D005260:Female; D006801:Humans; D008327:Mammography; D008403:Mass Screening; D011230:Precancerous Conditions / Q000473:pathology*; D012680:Sensitivity and Specificity